Risk factors | Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
HR1 | 95% CI2 | p-value | Adjusted HR1 | 95% CI2 | p-value | |
Male | 0.87 | [0.79–0.97] | 0.014 | |||
Age | < 0.001* | < 0.001* | ||||
< 40 years | 1 | – | – | 1 | – | – |
40–59 years | 0.65 | [0.54–0.78] | < 0.001 | 0.70 | [0.58–0.85] | < 0.001 |
60–69 years | 0.54 | [0.44–0.66] | < 0.001 | 0.63 | [0.51–0.77] | < 0.001 |
70–74 years | 0.49 | [0.39–0.62] | < 0.001 | 0.58 | [0.46–0.74] | < 0.001 |
75–80 years | 0.45 | [0.36–0.57] | < 0.001 | 0.56 | [0.44–0.71] | < 0.001 |
≥ 80 years | 0.51 | [0.41–0.63] | < 0.001 | 0.62 | [0.50–0.78] | < 0.001 |
Body temperature ≥ 39 °C | 0.94 | [0.76–1.17] | 0.60 | |||
Diabetes | 0.78 | [0.68–0.90] | < 0.001 | – | – | – |
Obesity3 | 0.84 | [0.74–0.95] | 0.006 | 0.85 | [0.75–0.96] | 0.012 |
Vasopressors use | 0.70 | [0.63–0.78] | < 0.001 | 0.78 | [0.70–0.87] | < 0.001 |
Immunosuppression | 0.62 | [0.51–0.75] | < 0.001 | 0.64 | [0.52–0.77] | < 0.001 |
Creatinine > 100 µmol/L | 0.59 | [0.53–0.66] | < 0.001 | 0.66 | [0.59–0.74] | < 0.001 |